Patent · US Active

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

US8808697B2 · kind B2 · utility

3Cited by

2References

6Claims

0Family size

Assignee

ONCOIMMUNE, INC. · US

Inventors

Xincheng Zheng · Ann Arbor, US
Wei Wu · Washington, US
Yang Liu · Columbus, US
Pan Zheng · Ann Arbor, US

Key dates

Filing date	Apr 28, 2011
Grant date	Aug 19, 2014
Priority date	—
Expiry date	Apr 28, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is a method of treating rheumatoid arthritis using a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.